[Experience of Lucentis use in patients with wet age-related macular degeneration]. [electronic resource]
Producer: 20121228Description: 26-31 p. digitalISSN:- 0042-465X
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Choroidal Neovascularization -- complications
- Disease Management
- Efficiency, Organizational
- Female
- Humans
- Injections, Intraocular -- methods
- Male
- Middle Aged
- Product Line Management -- organization & administration
- Ranibizumab
- Siberia
- Standard of Care
- Tomography, Optical Coherence -- methods
- Treatment Outcome
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: English Abstract; Journal Article
There are no comments on this title.
Log in to your account to post a comment.